Skip to content

OABI

OmniAb, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.18
+0.58%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
24.98x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.03x
Price / sales
18.80x
Price / cash flow
283.40x

Enterprise value

Enterprise value
$709.5M
EV / sales
17.66x
EV / EBITDA
-32.90x
EV / EBIT
-15.24x
Market cap
$755.6M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026